Shanghai-Based Biopharma Strikes Deal With Canadian Firm To Bring mRNA Covid Vaccine In China
Neither Sinopharm Nor Sinovac, China Plans To Use Fosun-BioNTech Covid-19 Vaccine As Booster Shot
Chinese Covid-19 Vaccine Maker Sinopharm Publishes Most Awaited Study Details, Concerns About Trials Remain
Bangladesh To Buy 15 Million Doses Of Chinese Covid19 Vaccines, Offers Joint Production Facilities To Pune’s Serum Institute
Third Dose In UAE And Bahrain Raises Concern Over Efficacy Of Chinese Vaccine: Here's What Experts Think
Covid-19 Cases Rising in Seychelles, Where Majority Of People Received China’s Sinopharm Vaccine
